Cipla inks licensing deal with Gilead for potential Covid-19 treatment
Remdesivir is an investigational medicine that has been granted the US Food and Drug Administration (FDA) EUA to…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 May 20
Remdesivir is an investigational medicine that has been granted the US Food and Drug Administration (FDA) EUA to…
08 May 20
ZYUS will leverage its bio-pharmaceutical plant technology platform and expertise to develop and express VIDO-InterVac’s protein
05 May 20
Lilly will receive an exclusive license for clinical development, manufacturing and distribution of products outside of Greater China,…
01 May 20
The collaboration between AstraZeneca and Oxford University will enable global development, manufacturing and distribution of the new COVID-19…
23 Apr 20
BioNTech and Pfizer have joined forces to develop BNT162, the vaccine that has potential to prevent the COVID-19…
07 Apr 20
Both GSK, Vir Biotechnology will apply their combined expertise to research on vaccines for SARS-CoV-2 and other coronaviruses
06 Apr 20
Samsung will provide the full scope of its CDO services including cell line development, process development, cGMP clinical…
26 Mar 20
Under the collaboration, BrightInsight and AstraZeneca will initially focus on the chronic disease management space
13 Mar 20
Thermo Fisher will collaborate with Janssen Research & Development to validate multiple biomarkers to be used with its…
28 Feb 20
The drugs will be developed using Sangamo’s zinc finger protein (ZFP) technology, which is delivered through adeno-associated virus…